Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

Drug repositioning is the only feasible option to immediately address the COVID-19 global challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which were preselected by an assay of SARS-CoV. We identified 24 potential antiviral...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Antimicrob Agents Chemother
Egile Nagusiak: Jeon, Sangeun, Ko, Meehyun, Lee, Jihye, Choi, Inhee, Byun, Soo Young, Park, Soonju, Shum, David, Kim, Seungtaek
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2020
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318052/
https://ncbi.nlm.nih.gov/pubmed/32366720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00819-20
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak